DOI: 10.2337/dc06-0711 © 2007 by the American Diabetes Association
Signs of ß-Cell Autoimmunity in Nondiabetic SchoolchildrenA comparison between Russian Karelia with a low incidence of type 1 diabetes and Finland with a high incidence rate
1 Department of Virology, University of Tampere Medical School, Tampere, Finland Address correspondence and reprint requests to Mikael Knip, MD, PhD, Hospital for ChildrenAdolescents, University of Helsinki, P.O. Box 281, FIN-00029 HUCH, Helsinki, Finland. E-mail: mikael.knip{at}hus.fi OBJECTIVEWe sought to study the prevalence of autoantibodies to various islet cell antigens in the background population of two neighboring countries with a sixfold difference in the incidence of type 1 diabetes. RESEARCH DESIGN AND METHODSSerum samples were obtained from 3,652 nondiabetic schoolchildren in Finland and from 1,988 schoolchildren in the adjacent Karelian Republic of Russia. The Karelian children were divided into three groups (Finns/Karelians, Russians, and others) based on the ethnic background of their mother. The samples were analyzed for islet cell antibodies (ICAs), insulin autoantibodies (IAAs), GAD antibodies (GADAs), and the tyrosine phosphatase-like insulinoma antigen 2 (IA-2A) protein and HLA class II genotypes.
RESULTSThe frequency of ICAs, IAAs, and GADAs did not differ significantly between the Karelian (3.5, 0.6, and 0.9%, respectively) and Finnish children (2.8, 0.9, and 0.5%, respectively). Similarly, the frequency of multiple ( CONCLUSIONSThese data indicate that ß-cell autoimmunity among schoolchildren is as frequent in Russian Karelia as in Finland, although the incidence of clinical type 1 diabetes is six times higher in Finland. However, in contrast to this general trend, IA-2As were more common in Finland. Since IA-2As usually appear late in the preclinical process, this suggests that progressive ß-cell autoimmunity is more rare in Russian Karelia.
Abbreviations: DASP, Diabetes Autoantibody Standardization Program GADA, GAD antibody IAA, insulin autoantibody IA-2A, tyrosine phosphatase-like insulinoma antigen 2 ICA, islet cell antibody JDFU, Juvenile Diabetes Foundation units
This article has been cited by other articles:
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||